BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hamdy R, Mostafa A, Abo Shama NM, Soliman SSM, Fayed B. Comparative evaluation of flavonoids reveals the superiority and promising inhibition activity of silibinin against SARS-CoV-2. Phytother Res 2022. [PMID: 35596627 DOI: 10.1002/ptr.7486] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Xu X, Chen Y, Lu X, Zhang W, Fang W, Yuan L, Wang X. An update on inhibitors targeting RNA-dependent RNA polymerase for COVID-19 treatment: Promises and challenges. Biochem Pharmacol 2022;205:115279. [PMID: 36209840 DOI: 10.1016/j.bcp.2022.115279] [Reference Citation Analysis]
2 Gupta Y, Savytskyi OV, Coban M, Venugopal A, Pleqi V, Weber CA, Chitale R, Durvasula R, Hopkins C, Kempaiah P, Caulfield TR. Protein structure-based in-silico approaches to drug discovery: Guide to COVID-19 therapeutics. Molecular Aspects of Medicine 2022. [DOI: 10.1016/j.mam.2022.101151] [Reference Citation Analysis]
3 Musazadeh V, Karimi A, Bagheri N, Jafarzadeh J, Sanaei S, Vajdi M, Karimi M, Niazkar HR. The favorable impacts of silibinin polyphenols as adjunctive therapy in reducing the complications of COVID-19: A review of research evidence and underlying mechanisms. Biomed Pharmacother 2022;154:113593. [PMID: 36027611 DOI: 10.1016/j.biopha.2022.113593] [Reference Citation Analysis]